Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ursula Anne Matulonis, M.D.

Concepts (643)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Ursula Matulonis's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Ursula Matulonis has written about over time.
Fallopian Tube Neoplasms, 19 publications between 2003 and 2024, average publication date November 2011. Genital Neoplasms, Female, 16 publications between 2003 and 2024, average publication date May 2012. Peritoneal Neoplasms, 28 publications between 2001 and 2024, average publication date September 2012. Neoplasms, Glandular and Epithelial, 18 publications between 2004 and 2018, average publication date November 2012. Antineoplastic Combined Chemotherapy Protocols, 74 publications between 1999 and 2024, average publication date February 2015. Antineoplastic Agents, 59 publications between 2004 and 2024, average publication date March 2015. Cystadenocarcinoma, Serous, 23 publications between 2003 and 2021, average publication date September 2015. Ovarian Neoplasms, 199 publications between 2000 and 2024, average publication date February 2016. Endometrial Neoplasms, 25 publications between 2003 and 2023, average publication date May 2016. Neoplasm Recurrence, Local, 78 publications between 2001 and 2024, average publication date July 2016. Piperazines, 28 publications between 2010 and 2024, average publication date May 2017. Phthalazines, 33 publications between 2010 and 2024, average publication date October 2017. BRCA2 Protein, 25 publications between 2013 and 2024, average publication date September 2018. BRCA1 Protein, 27 publications between 2013 and 2024, average publication date September 2018. Indazoles, 15 publications between 2014 and 2023, average publication date February 2019. Maytansine, 10 publications between 2016 and 2024, average publication date August 2020. Immunoconjugates, 15 publications between 2016 and 2024, average publication date September 2020. Folate Receptor 1, 11 publications between 2016 and 2024, average publication date May 2021.

To see the data from this visualization as text, click here.
Matulonis's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (643)
Explore
_
Co-Authors (243)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.